Page last updated: 2024-08-26

5,6-dihydrouridine and Glioma

5,6-dihydrouridine has been researched along with Glioma in 1 studies

*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battastini, AM; Figueiró, F; Hoppe, JB; Jandrey, EH; Montes D'Oca, Cda R; Montes D'Oca, MG; Piovesan, LA; Rosa, SB; Russowsky, D; Salbego, CG; Taborda, PS; Treptow, TG1

Other Studies

1 other study(ies) available for 5,6-dihydrouridine and Glioma

ArticleYear
Novel hybrid DHPM-fatty acids: synthesis and activity against glioma cell growth in vitro.
    European journal of medicinal chemistry, 2015, May-05, Volume: 95

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Fatty Acids; Glioma; Humans; Male; Rats; Rats, Wistar; Uridine

2015